Two of a kind: China's first pet cloning service duplicates star pooch
FILE PHOTO: A Beagle with the ID number NTR1917, who is the surrogate mother of the 24 day-old clone of Juice, shares an enclosure with its offspring at the biotech company Sinogene in Beijing, China October 11, 2018. REUTERS/Jason Lee
BEIJING (Reuters) - Juice is a one-foot tall canine wonder who has starred in dozens of Chinese film and television productions.
As he gets older and his illustrious career peaks, his Beijing-based master has one wish for the mutt - to live on. Maybe forever.
FILE PHOTO: Twenty-four-day old clone of Juice feeds off its surrogate mother, a Beagle dog with the ID number NTR1917, at the biotech company Sinogene in Beijing, China October 11, 2018. REUTERS/Jason Lee
A mongrel stray adopted off the streets, the nine year-old Juice -- or "Guozhi" in Mandarin -- is unable to reproduce since he was neutered from an early age. But his master, animal trainer He Jun, wants to continue his star pooch's image by making a genetic clone.
"Juice himself is a piece of intellectual property with social influence," said He.
To achieve that, He went to Sinogene, China's first biotech company to provide pet cloning services. Sinogene made headlines when it successfully cloned a gene-edited beagle in May last year. A month later, it launched commercial cloning services.
Nine-year-old Juice looks at its two-month-old clone at He Jun's pet resort in Beijing, China November 26, 2018. Picture taken November 26, 2018. REUTERS/Jason Lee
For at least 380,000 yuan ($55,065), pet owners can clone their pets.
Sinogene's CEO Mi Jidong said the company's pet cloning business is in its initial stages, but he plans to expand services to eventually include gene editing.
"We've discovered that more and more pet owners want their pets to accompany them for an even longer period of time," said Mi.
Veterinary doctors conduct a surgery on a Beagle dog in an attempt to make it the surrogate mother of a clone of the dog Juice at a lab of the biotech company Sinogene in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas Peter
China's biotech industry is growing rapidly and, compared with similar enterprises in the West, faces relatively few regulatory barriers.
Earlier this year, a Shanghai lab produced the world's first monkey clones, two long-tailed macaques. More controversially, He Jiankui of China's Southern University of Science and Technology last month claimed he used gene-editing technology to alter the embryonic genes of twin girls.
Tin-Lap Lee, an associate professor of biomedical sciences at the Chinese University of Hong Kong, said while China has regulations on the use of animals for lab research, there are no laws explicitly covering animal cloning.
A lab technician demonstrates gene-editing software at a lab of the biotech company Sinogene that specialises in dog cloning in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas Peter
"On the government side, the image of this cloning industry is very high-tech, and definitely...is very supportive of those high-tech industries because of their high-profit margin," said Lee.
In Juice's case, skin samples were collected from the dog's lower abdomen and within weeks, Sinogene was able to isolate his DNA and fertilize an egg.
The fertilized egg is then surgically inserted into the uterus of a surrogate mother dog - in this case a beagle.
A technician works with genome samples at a lab of the biotech company Sinogene that specialises in dog cloning, in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas Peter
Juice's copy, "Little Juice" -- or "Zhizhi" in Chinese -- was born in mid-September and stayed with its surrogate mother in Sinogene's lab for about a month. The puppy was later given to He at a small ceremony at which the original Juice was present.
While He has not committed Little Juice to show business just yet, he sees lots of potential.
"We believe he'll be even better than the older Juice," He said.
Owner He Jun poses with his dogs, nine-year-old Juice and its two-month-old clone, at his pet resort in Beijing, China November 26, 2018. Picture taken November 26, 2018. REUTERS/Jason Lee
(Reporting by Joseph Campbell; Editing by Sam Holmes)
Owner He Jun poses with a two-month-old clone of his dog Juice next to a movie poster showing source dog Juice, at his pet resort in Beijing, China November 21, 2018. Picture taken November 21, 2018. REUTERS/Jason LeeA staff member holds 24-day-old clone of Juice at the biotech company Sinogene in Beijing, China October 11, 2018. Picture taken October 11, 2018. REUTERS/Jason LeeStaff prepare a Beagle dog for surgery attempting to make it the surrogate mother of a clone of the dog Juice at a lab of the biotech company Sinogene in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas PeterOwner He Jun poses with his dog Juice at his pet resort in Beijing, China June 7, 2018. Picture taken June 7, 2018. REUTERS/Damir SagoljOwner He Jun poses with a two-month-old clone of his dog Juice next to a movie poster showing source dog Juice, at his pet resort in Beijing, China November 21, 2018. Picture taken November 21, 2018. REUTERS/Jason LeeSinogene CEO Mi Jidong (2nd R) and staff of the biotech company that specialises in animal cloning, hand over a one-month-old puppy, a clone of the nine-year-old Juice, to his owner He Jun (L) at the company's head office in Beijing, China, October 22, 2018. Picture taken October 22, 2018. REUTERS/Thomas PeterSinogene staff shows a gene sample from dog Juice at He Jun's pet resort in Beijing, China June 7, 2018. Picture taken June 7, 2018. REUTERS/Damir SagoljA framed picture shows Chinese actress Ni Ni holding Juice, a dog that served as the genetic source for its clone that is to continue in its footsteps as a movie star, at He Jun's pet resort in Beijing, China November 21, 2018. Picture taken November 21, 2018. REUTERS/Jason Lee Sinogene staff extract a gene sample from 9 year-old Juice at He Jun's pet resort in Beijing, China June 7, 2018. Picture taken June 7, 2018. REUTERS/Damir SagoljThe 9 year-old Juice rests at He Jun's pet resort in Beijing, China June 7, 2018. Picture taken June 7, 2018. REUTERS/Damir SagoljStaff prepare a Beagle dog for surgery attempting to make it the surrogate mother of a clone of the dog Juice at a lab of the biotech company Sinogene in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas PeterTwenty-four-day old clone of Juice feeds off its surrogate mother, a Beagle dog with the ID number NTR1917, at the biotech company Sinogene in Beijing, China October 11, 2018. Picture taken October 11, 2018. REUTERS/Jason LeeA screen displays the microscopic image of an attempt to inseminate a dog egg at a lab of the biotech company Sinogene that specialises in dog cloning in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas PeterVeterinary doctors conduct a pregnancy test on Beagle dog NTR1917, the surrogate mother of a clone of the dog Juice, at the biotech company Sinogene in Beijing, China September 10, 2018. Picture taken September 10, 2018. REUTERS/Jason LeeOwner He Jun poses with his dogs, nine-year-old Juice and its two-month-old clone, at his pet resort in Beijing, China November 26, 2018. Picture taken November 26, 2018. REUTERS/Jason Lee
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.